NAD+ Benefits: What the Evidence Actually Shows
Summary: The literature is large. The question is which intervention it studied, because precursor capsules and intravenous NAD+ are not the same exposure.
This content is for informational purposes only and is not medical advice. Always consult a qualified healthcare provider before starting, changing, or stopping any medication.
NAD+ benefits are advertised for energy, mental clarity, ageing, recovery and addiction. The literature behind those words is genuinely large, which makes this compound different from everything else covered on this site, where the usual problem is that almost nothing has been studied in people.
The problem here is the opposite shape. A great deal has been studied in people. Much of it studied something other than the product being sold.
Most controlled human research in this area tested oral precursors, principally nicotinamide riboside and nicotinamide mononucleotide, taken as capsules and converted inside the body. The product sold in a clinic or a vial is NAD+ itself, delivered into a vein or under the skin. Those are different interventions by different routes, and evidence for one does not automatically transfer to the other.
Where readers actually buy it
Ascension Peptides — NAD+
Research-grade NAD+, tested by two outside labs and shipped from the US. The code below takes half off the vial.
Quoted per 100 mg because NAD+ is dosed in hundreds of milligrams, not the single milligrams a peptide vial holds. Buying 3, 5 or 10 takes 3%, 5% or 10% off the list price. Free shipping starts at $250.
- Batch certificates from two independent labs
- Free shipping over $250
- Ships same day if ordered before 2pm CST
Sold for laboratory research only and not for human consumption. These are affiliate links: we may earn a commission at no cost to you, and it does not change what we recommend. Prices checked August 20, 2026.
The substitution that happens inside a single sentence
Watch how it works. A page writes: NAD+ has been studied extensively in humans, with hundreds of clinical trials.
Every clause in that sentence can be defended, and the sentence as a whole is still misleading. The trials exist. The humans are real. But the intervention in most of them was a precursor capsule, and the reader has just been told something about a bag of fluid on a drip stand. Nobody had to lie. The word NAD+ covers a molecule, a family of precursors and a commercial product, and letting all three share one name does the work.
The correction is small and it costs one clause: which intervention was studied, and by which route. A source that will not say is not a source you can evaluate, and nearly every NAD+ benefits claim in circulation can be sorted with that one question.
NAD+ benefits, and the intervention behind each claim
| Claimed benefit | Which intervention the human work mostly used | Organism | What has not been shown |
|---|---|---|---|
| More energy, less fatigue | Oral precursors, NR and NMN | Human | That an infusion of NAD+ produces a felt energy change against a placebo |
| Sharper focus or clarity | Oral precursors, and cell and animal work on brain metabolism | Human, mouse, cell culture | That injected NAD+ changes measured cognition in people |
| Slower ageing | Largely mouse and cell culture work on NAD biology | Mouse, cell culture | Any effect on human ageing from any route |
| Faster physical recovery | Oral precursors in humans, plus animal metabolic work | Human, mouse | That infused NAD+ speeds recovery in people |
| Help with withdrawal or craving | Clinic accounts and uncontrolled reports | Human | Anything controlled. This is the thinnest claim of the group |
| Raised NAD levels in tissue | Oral precursors in humans; animal work for other routes | Human, mouse | That a raised level produces an outcome a person notices |
The last row is the one to sit with. Even where a measured level moves, the step from a moving marker to a benefit a person would report is a separate claim requiring separate evidence.
The second column is the whole article
Cover the first column of that table and the page still makes sense. Cover the second and it stops being informative, because the claim and its support have been separated.
That is the practical test to carry away, and most NAD+ benefits pages fail it. When a benefit is stated, ask what was given, to whom, and by what route. Most pages in this category answer the first question with a word that covers three different things and never answer the other two at all.
There is a related counting habit worth refusing. Sources in this area like to cite the size of the literature: so many published records, so many registered trials. A number like that is only meaningful attached to an intervention. Records mentioning NAD biology include decades of basic biochemistry that involved no people and no product. Registered trials include studies of oral precursors, studies in patients with specific conditions, and studies measuring markers rather than outcomes. Collapsing all of that into one impressive figure and placing it next to a photograph of a drip bag is a rhetorical move, not a summary of evidence.
Energy is the word carrying the most weight
Energy is the most repeated of the NAD+ benefits claims, and it is where the reasoning is thinnest. NAD+ is central to cellular energy metabolism. That is real biochemistry, and it is where the marketing starts.
But cellular energy metabolism and the feeling of having energy are not the same thing, and the slide between them is the most common move in this category. Cellular energy metabolism refers to how cells convert substrates into usable chemical energy. Feeling energetic is a subjective human experience shaped by sleep, mood, hydration, illness, thyroid function, iron status, medication and expectation. A molecule can be essential to the first without altering the second in a person who is not deficient.
This matters because feeling is also the outcome most vulnerable to expectation. A person who has paid for an infusion, sat in a clinic for an hour and been told to expect a lift is very likely to report a lift. That is not dishonesty on their part. It is how subjective outcomes behave, and it is precisely why trials use placebo comparisons and blinding. Uncontrolled reports of feeling better after an expensive intervention are the weakest evidence available for the outcome most often claimed.
What a precursor trial can and cannot lend
It would be wrong to say precursor research is irrelevant to the injected product. It establishes that the biology is worth investigating, it tells you something about how the body handles related molecules, and it has produced human safety information for the precursors themselves.
What it cannot do is stand in for the missing work. Route changes almost everything about an exposure: how much reaches the bloodstream, how fast, what concentration peaks look like, what the body does with it before it arrives, and which tissues see it. A capsule that is absorbed, processed and converted over hours is a different event from a bag infused into a vein over an hour. Pharmacology treats route as a defining feature of an intervention, not a delivery detail, and so should a reader.
The honest formulation is available and short. Oral precursor trials in humans studied oral precursors. Injected NAD+ needs its own trials, and its evidence base is much thinner.
The setting is part of what people are buying
Infusion clinics sell an experience as well as a molecule: an appointment, a comfortable chair, an hour without a phone, attention from staff, and often a package alongside other infusions and vitamins.
Each of those elements can plausibly change how someone feels afterwards, and none of them is NAD+. A trial exists to separate the molecule from everything wrapped around it. A clinic has no reason to do that separation and every commercial reason not to, which is why testimonials from that setting cannot distinguish the drug from the day off.
There is a further complication where the infusion is one item on a menu. If someone receives several things at once, no report afterwards can attribute the result to any single component. Bundling is convenient commercially and it makes the evidence uninterpretable.
What evidence for the injected product would look like
It is worth stating the target, because it is not exotic and it is not unreachable.
It would be a randomised trial in humans, comparing infused NAD+ against a placebo infusion, with participants and assessors blinded to which they received. It would measure a defined outcome chosen in advance rather than collecting impressions afterwards. It would report on everyone who enrolled, including those who withdrew. And it would be replicated by a group with no commercial interest in the result.
None of that is unusual. It is the ordinary standard the medicines in your cabinet met. The reason to keep it in mind is that once you know what the real thing looks like, testimonial pages stop resembling it, and the difference becomes obvious rather than something you have to argue about.
Pushback worth answering
- Are any NAD+ benefits established in humans?
- For oral precursors, human trials exist and have measured various outcomes, and any specific claim should name the precursor and the outcome. For injected or infused NAD+, the controlled human evidence is much thinner, and the popular claims about energy and clarity are not established by it.
- Everyone I know who tried an infusion says it worked. Does that count?
- It counts as reports, and reports of subjective improvement after a paid, attended, hour long intervention are exactly the kind of evidence a placebo comparison exists to interpret. The consistency of the reports does not fix the problem, because expectation is consistent too.
- Is it safe, given the body makes it anyway?
- Endogenous production says nothing about an infusion of a manufactured version at an unestablished quantity. There is no approved product, therefore no labelled adverse effect list and no obligatory reporting channel collecting harms.
- Is an oral precursor a better choice then?
- It is a different choice with a different evidence base, and it is the one most of the human trials actually tested. That is a statement about where the research is, not a recommendation. Anything you take is worth discussing with a clinician who knows your medications.
- What is the fastest way to judge a claim I read?
- Look for the intervention and the route. If a sentence about human trials does not say whether it means an oral precursor or injected NAD+, treat it as unfinished rather than as evidence.